Table 2 Study outcomes in the two treatment groups
No myo-inositol | Yes myo-inositol | p | |
|---|---|---|---|
Group A | Group B | ||
N = 50 | N = 50 | ||
No. oocytes retrieved/patient | 7.6 ± 3.8 | 5.9 ± 2.4 | <0.01 |
Mean ± SD | |||
No. metaphase II/patient | 6.3 ± 2.9 | 4.8 ± 2.2 | <0.05 |
Mean ± SD | |||
No. inseminated eggs/patient | 6 ± 2.7 | 4.8 ± 2.2 (240) | <0.05 |
Mean ± SD | |||
No. 2PN oocytes/patient | 4.3 ± 2.3 | 3.3 ± 1.8/163 | <0.01 |
Mean ± SD | |||
Fertilization rate (2PN/inseminated oocytes) | 70.8 ± 20.4 | 68.4 ± 19.2 | 0.7 |
(%) ± SD | |||
No. Embryos/patient | 3.58 ± 2.1 | 2.5 ± 1 .1 | <0.001 |
Mean ± SD | |||
Cleavage rate (embryos/2PN oocytes) | 82.2 ± 29.9 | 84.5 ± 28.7 | 0.7 |
(%) ± SD | |||
No. embryos Grade I and II : number | 173 (96.6%) | 117 (93.6%) | 0.2 |
and percentage of total | |||
No. of patients receiving | 1 | 47 (94%) | 1 |
embryos (%) | |||
No. of embryos transferred per | 2.4 ± 1 | 2.2 ± 0.8 | 0.39 |
starting patients Mean ± SD | |||
No. Clinical pregnancies | 12/47 (25.5%) | 14/47 (29.8%) | 0.52 |
No. of fetal hearts | 16 (13.3%) | 21 (18.7%) | 0.08 |
(implantation rate) |